Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Cervical Cancer and HPV Research

Cervical Cancer and HPV Research is a research topic within Epidemiology. Science Explorer counts 56k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, burden, and prevention of cervical cancer associated with Human Papillomavirus (HPV) infection. It covers topics such as HPV vaccination, viral oncogenes, genotype distribution, cytology screening, and the global burden of HPV-related cancers.

  • Human Papillomavirus
  • Cervical Cancer
  • HPV Vaccination
  • Epidemiology
  • Cancer Incidence
  • Cytology Screening
  • Viral Oncoproteins
  • Carcinogenicity
  • Genotype Distribution
  • Global Burden
Research works
56k
fractional, since 1950
In the world top 10%
5.6k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+14%
the tick is no change
Largest producer
United States
36% of the 10 largest, 2022-now
Cervical Cancer and HPV Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cervical Cancer and HPV Research research?

By volume, the United States and China publish the most (2.5k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.5k works
  2. 2 China 1.4k works
  3. 3 India 913 works
  4. 4 Brazil 402 works
  5. 5 United Kingdom 380 works
  6. 6 Italy 305 works
  7. 7 Türkiye 287 works
  8. 8 Japan 261 works
  9. 9 Germany 245 works
  10. 10 Nigeria 241 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 36.2%China: 20.5%India: 13.0%Brazil: 5.7%6 others listed: 24.5%36%largest
United States2,538 · 36.2%China1,436 · 20.5%India913 · 13.0%Brazil402 · 5.7%6 others listed1,720 · 24.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cervical Cancer and HPV Research research?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Cervical Cancer and HPV Research research, followed by Harvard University and National Institutes of Health.

By volume, 2022-now

  1. 1 University of North Carolina at Chapel HillUnited States 151 works
  2. 2 Harvard UniversityUnited States 77 works
  3. 3 National Institutes of HealthUnited States 62 works
  4. 4 All India Institute of Medical SciencesIndia 61 works
  5. 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 51 works
  6. 6 Johns Hopkins UniversityUnited States 50 works
  7. 7 The University of Texas MD Anderson Cancer CenterUnited States 48 works
  8. 8 Karolinska InstitutetSweden 41 works
  9. 9 Peking UniversityChina 37 works
  10. 10 Sichuan UniversityChina 37 works

Who are the leading researchers in Cervical Cancer and HPV Research?

The most-cited researchers publishing on Cervical Cancer and HPV Research include David Moher, Ahmedin Jemal and Christopher J L Murray.

  1. 1 David Moher Canada 898k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Rebecca L. Siegel United States 582k citations
  5. 5 Freddie Bray France 550k citations
  6. 6 Jacques Ferlay France 486k citations
  7. 7 George Davey Smith United Kingdom 435k citations
  8. 8 Walter Churchill Willett United States 411k citations
  9. 9 Gad A. Getz United States 364k citations
  10. 10 Hermann Brenner Germany 343k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cervical Cancer and HPV Research?

The most cited paper in Cervical Cancer and HPV Research is "Global cancer statistics" (Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al., 2011), with 55,108 citations. Next come "Global Cancer Statistics, 2002" (18,430) and "Cancer statistics, 2023" (17,031).

Most cited papers
#PaperReleasedCitations
1 Global cancer statistics Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians Open access 4 Feb 2011 55,108
2 Global Cancer Statistics, 2002 Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians Open access Mar 2005 18,430
3 Cancer statistics, 2023 Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians Open access 2023 17,031
4 Cancer statistics, 2024 Rebecca L. Siegel, Angela N. Giaquinto, Ahmedin Jemal · CA A Cancer Journal for Clinicians Open access 2024 9,500
5 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology Open access Sep 1999 9,115
All 100 most cited papers, with filters and sorting

Where is Cervical Cancer and HPV Research research done?

The largest centres of Cervical Cancer and HPV Research research in 2022-now are Beijing (China), Chapel Hill (United States), London (United Kingdom) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in San Juan.

Largest cities, 2022-now

  1. 1 BeijingChina 207 works
  2. 2 Chapel HillUnited States 148 works
  3. 3 LondonUnited Kingdom 147 works
  4. 4 ShanghaiChina 118 works
  5. 5 New YorkUnited States 116 works
  6. 6 SeoulSouth Korea 109 works
  7. 7 HoustonUnited States 98 works
  8. 8 New DelhiIndia 97 works
  9. 9 TehranIran 93 works
  10. 10 São PauloBrazil 88 works

Where it is the local speciality

  1. San JuanPR · 32.8 works14×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cervical Cancer and HPV Research than the world average.

See Cervical Cancer and HPV Research on the map

Where is the best place to study Cervical Cancer and HPV Research?

Among universities, judged by research, University of Gondar, Karolinska Institutet and University of North Carolina at Chapel Hill score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.8%fractional works in this field (log) →share of work in the world top 10% →University of GondarLondon School of Hyg…Karolinska InstitutetUniversity of North …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of GondarEthiopia 67.734.2%9.9×15 +60.4%
2Karolinska InstitutetSweden 65.720.8%7.2×41 +13.1%
3University of North Carolina at Chapel HillUnited States 59.04.6%8.3×151 +30.0%
4London School of Hygiene & Tropical MedicineUnited Kingdom 59.023.8%10.5×17 -7.9%
5Harvard UniversityUnited States 54.512.7%2.4×77 -5.1%
6University of British ColumbiaCanada 53.815.6%2.7×33 +18.6%
7Johns Hopkins UniversityUnited States 52.815.8%3.2×50 -9.7%
8McGill UniversityCanada 52.314.0%2.7×27 +31.5%
9Chinese University of Hong KongChina 52.216.5%2.7×20 +55.3%
10Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 49.920.0%4.8×51 -6.3%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cervical Cancer and HPV Research, country by country

Is Cervical Cancer and HPV Research research growing?

Output in 2022-2025 was 14% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cervical Cancer and HPV Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cervical Cancer and HPV Research as a percentage of every work published that year, 0.049% in 2024.

still counting0.025%0.050%0.075%Cervical Cancer and HPV Research0.049% in 202519801990200020102020

Fractional works of Cervical Cancer and HPV Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cervical Cancer and HPV Research10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who is researching a cure for HPV?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Cervical Cancer and HPV Research research, followed by Harvard University and National Institutes of Health. By volume, the United States and China publish the most (2.5k and 1.4k works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Cervical Cancer and HPV Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.